RF Acquisition Corp II announced on October 2, 2025, that it entered into a Business Combination Agreement to merge with NYB Holdings Limited and amalgamate with Nanyang Biologics, creating a single entity. This merger involves converting ordinary shares from both companies into new shares of PubCo, with existing RFAC II shares ceasing to exist in exchange for PubCo shares.